EGFR-mutated metastatic NSCLC — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — EGFR-mutated metastatic lung adenocarcinoma with CNS involvement
The histology, metastatic distribution and EGFR exon 19 deletion define EGFR-mutated metastatic lung adenocarcinoma with brain metastases. Small-cell cancer and ALK-rearranged disease are different molecular and histological entities. Stage I disease and benign adenoma are excluded by metastatic CNS involvement and malignant histology.
Reference: NICE NG122; NICE EGFR inhibitor technology appraisals